JP2008536815A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008536815A5 JP2008536815A5 JP2008501999A JP2008501999A JP2008536815A5 JP 2008536815 A5 JP2008536815 A5 JP 2008536815A5 JP 2008501999 A JP2008501999 A JP 2008501999A JP 2008501999 A JP2008501999 A JP 2008501999A JP 2008536815 A5 JP2008536815 A5 JP 2008536815A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- thioether bridge
- population
- cysteine residue
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66172405P | 2005-03-14 | 2005-03-14 | |
| US69913805P | 2005-07-13 | 2005-07-13 | |
| PCT/US2006/009311 WO2006099481A2 (en) | 2005-03-14 | 2006-03-14 | Macromolecules comprising a thioether cross-link |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008536815A JP2008536815A (ja) | 2008-09-11 |
| JP2008536815A5 true JP2008536815A5 (enExample) | 2009-05-21 |
Family
ID=36992404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008501999A Abandoned JP2008536815A (ja) | 2005-03-14 | 2006-03-14 | チオエーテル架橋を含む巨大分子 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7786273B2 (enExample) |
| EP (1) | EP1858911A4 (enExample) |
| JP (1) | JP2008536815A (enExample) |
| AU (1) | AU2006223002A1 (enExample) |
| CA (1) | CA2600844A1 (enExample) |
| WO (1) | WO2006099481A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009532027A (ja) * | 2006-03-28 | 2009-09-10 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 抗ｉｇｆ−１ｒ抗体およびその使用 |
| CA2697922A1 (en) * | 2007-08-28 | 2009-03-12 | Biogen Idec Ma Inc. | Compositions that bind multiple epitopes of igf-1r |
| JP2010537985A (ja) * | 2007-08-28 | 2010-12-09 | バイオジェン アイデック マサチューセッツ インコーポレイテッド | 抗ｉｇｆ−１ｒ抗体およびその使用 |
| WO2009028639A1 (ja) | 2007-08-30 | 2009-03-05 | Daiichi Sankyo Company, Limited | 抗ｅｐｈａ２抗体 |
| BRPI0819063A2 (pt) | 2007-11-27 | 2020-08-18 | The University Of British Columbia | método para tratamento de artrite, anticorpo, hibridoma, antagonista de 14-3-3, usos de um antagonista de 14-3-3, composições farmacêuticas, método para redução da expressão de mmp no sinóvio de um paciente e usos de uma composição farmacêutica |
| WO2009126304A1 (en) * | 2008-04-11 | 2009-10-15 | Biogen Idec Ma Inc. | Therapeutic combinations of anti-igf-1r antibodies and other compounds |
| KR20150084836A (ko) * | 2012-11-05 | 2015-07-22 | 메디뮨 엘엘씨 | 벤조나아제 부재 하의 시나지스 분리 방법 |
| BR112017008383A2 (en) * | 2014-10-31 | 2018-07-31 | Medimmune, Llc | improved production method |
| GB201603291D0 (en) | 2016-02-25 | 2016-04-13 | Binding Site Group The Ltd | Antibodies |
| US20190048064A1 (en) * | 2016-02-25 | 2019-02-14 | The Binding Site Group Limited | Antibodies |
| WO2018075954A2 (en) | 2016-10-21 | 2018-04-26 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| AU2017345786B2 (en) | 2016-10-21 | 2024-08-01 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| US11312761B2 (en) | 2016-10-21 | 2022-04-26 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| GB201708262D0 (en) | 2017-05-23 | 2017-07-05 | Binding Site Group Ltd | Assay for plasma cell associated disease |
| CN108017717B (zh) * | 2018-01-24 | 2019-08-16 | 首都医科大学宣武医院 | 一种用于体外高效定向扩增的嵌合抗原受体及其应用 |
| CN113166236A (zh) * | 2018-09-21 | 2021-07-23 | 北卡罗来纳大学查佩尔希尔分校 | 限制穿过黏液的合成粘合剂 |
| GB202007047D0 (en) | 2020-05-13 | 2020-06-24 | Binding Site Group Ltd | Mass spectrometry controls |
| US20220268783A1 (en) * | 2021-02-19 | 2022-08-25 | Waters Technologies Corporation | Methods for peptide mapping of adeno-associated virus (aav) proteins |
| IL328264A (en) | 2023-11-14 | 2026-07-01 | Janssen Pharmaceuticals Inc | Anti-Respiratory Syncytial Virus Antibodies and Their Uses |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991003493A1 (en) * | 1989-08-29 | 1991-03-21 | The University Of Southampton | Bi-or trispecific (fab)3 or (fab)4 conjugates |
| US5091542A (en) * | 1990-03-09 | 1992-02-25 | Hybritech Incorporated | Tris-maleimido compounds as intermediates in trifunctional antibody synthesis |
| AU664855B2 (en) * | 1991-08-09 | 1995-12-07 | Winfried Kolbeck | Lanthionine bridged peptides |
| US6897044B1 (en) * | 1999-01-28 | 2005-05-24 | Biogen Idec, Inc. | Production of tetravalent antibodies |
| ATE328582T1 (de) * | 1999-04-23 | 2006-06-15 | Mitsubishi Chem Corp | Antikörper und polyalkylenglycol gebundenes liposom |
| US20060123504A1 (en) * | 2004-12-07 | 2006-06-08 | Avigenics, Inc. | Methods of producing polyclonal antibodies |
| US20060286548A1 (en) * | 2005-06-16 | 2006-12-21 | Gregory Liposky | Method of making recombinant human antibodies for use in biosensor technology |
-
2006
- 2006-03-14 CA CA002600844A patent/CA2600844A1/en not_active Abandoned
- 2006-03-14 AU AU2006223002A patent/AU2006223002A1/en not_active Abandoned
- 2006-03-14 EP EP06738376A patent/EP1858911A4/en not_active Withdrawn
- 2006-03-14 US US11/375,810 patent/US7786273B2/en not_active Expired - Lifetime
- 2006-03-14 JP JP2008501999A patent/JP2008536815A/ja not_active Abandoned
- 2006-03-14 WO PCT/US2006/009311 patent/WO2006099481A2/en not_active Ceased
- 2006-03-14 US US11/908,601 patent/US20090030187A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20230338T1 (hr) | Anti-sars-cov-2-spike-glikoprotein antitijela i fragmenti za vezivanje antigena | |
| CY1121424T1 (el) | Αντισωματα εναντι toy tgfbeta | |
| HRP20090517T1 (hr) | Protutijela na interleukin-10 | |
| JP2024038003A5 (enExample) | ||
| JP2022553324A5 (enExample) | ||
| PE20110225A1 (es) | Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5 | |
| JP2020508655A5 (enExample) | ||
| UA86605C2 (ru) | Антитело, которое содержит вариант исходного человеческого fс-участка | |
| EA200700136A1 (ru) | Анти-cd154-антитела | |
| JP2022545682A5 (enExample) | ||
| WO2005056600B1 (en) | Monoclonal antibodies that bind or neutralize dengue virus | |
| ES2379283T3 (es) | Proteínas de unión a albúmina sérica | |
| JP2020524510A5 (enExample) | ||
| MX2009012319A (es) | Polipeptidos que se unen a receptores fc con funciones efectoras modificadas. | |
| ATE469176T1 (de) | Modifizierter anti-tnf antikörper | |
| JP2008529529A5 (enExample) | ||
| JP2016531546A5 (enExample) | ||
| JP2005510246A5 (enExample) | ||
| JP2015510875A (ja) | 分泌様免疫グロブリンを含む組成物 | |
| JP2025506172A5 (enExample) | ||
| JP2023520969A5 (enExample) | ||
| WO2021130383A1 (en) | Method for the production of bispecific fcyriii x cd30 antibody construct | |
| RU2019121106A (ru) | Иммунотерапия с применением антител, связывающих белок 1 программируемой смерти клеток (pd-1) | |
| JP2023506834A5 (enExample) | ||
| JP2024546763A5 (enExample) |